发明授权
US07098332B2 5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones 失效
5,8-二氢-6H-吡啶并[2,3-d]嘧啶-7-酮

5,8-Dihydro-6H-pyrido[2,3-d]pyrimidin-7-ones
摘要:
The invention provides 5,8-dihydro-6H-pyrido[2,3-d]pyrimidin-7-one compounds that are selective inhibitors of KDR and FGFR kinases, and are useful in the treatment of cancers. The compounds have the generic structure I where Ar, Ar′, and R1 are as set forth in the present specification. The invention also provides pharmaceutical compositions containing these compounds and methods for their use.
公开/授权文献
信息查询
0/0